QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+116.23%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$89.7M
AUM Growth
+$89.7M
(-18%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-310.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
2
Closed
2
Top Buys
| 1 |
Tourmaline Bio
TRML
|
$2.29M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$223M |
| 2 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$55.3M |
| 3 |
Ventyx Biosciences
VTYX
|
$1.51M |
| 4 |
ELEV
Elevation Oncology
ELEV
|
$1.27M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Korro Bio
KRRO
$217M
| $33.1M | 36.93% |
368,085
| – | – |
|
|
2
Jasper Therapeutics
JSPR
$45.5M
| $27.3M | 30.41% |
928,964
-7,590,684
| -89% | -$223M |
|
|
3
Tourmaline Bio
TRML
$601M
| $17M | 18.94% |
741,691
+100,000
| +16% | +$2.29M |
|
4
HilleVax
HLVX
$105M
| $9.29M | 10.36% |
558,923
| – | – |
|
|
5
Ventyx Biosciences
VTYX
$171M
| $2.27M | 2.53% |
412,225
-274,145
| -40% | -$1.51M |
|
6
Kezar Life Sciences
KZR
$28.9M
| $747K | 0.83% |
828,711
| – | – |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| – | – |
-2,370,142
| Closed | -$1.27M |
|
|
ICVX
8
DELISTED
Icosavax, Inc. Common Stock
ICVX
| – | – |
-3,510,228
| Closed | -$55.3M |
|